Skip to main content
. 2016 May 6;7(24):36896–36908. doi: 10.18632/oncotarget.9213

Figure 6. Schematic diagram summarizes the mechanism of CCL5-mediated tumor lymphangiogenesis in human chondrosarcoma.

Figure 6

CCL5 promotes VEGF-C production by downregulating miR-507 in human chondrosarcoma cells, and subsequently induces lymphangiogenesis of human LECs.